![](/documents/10803/941785/Innovation+Moves+Online+for+the+2020+McGill+Clinical+Innovation+Competition+thumbnail.jpg/d0a397e6-77b0-d590-06fb-4f0773be897d?t=1591899516549)
Innovation Moves Online for the 2020 McGill Clinical Innovation Competition
RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize
![](/documents/10803/946541/Why+do+some+non-smokers+get+COPD+while+many+heavy+smokers+don%E2%80%99t+thumbnail.jpg/1519310e-23e3-e954-94ad-b6d96d3826e4?t=1591727514914)
Why do some non-smokers get COPD while many heavy smokers don’t?
A new study highlights a strong risk factor for COPD related to lung development
![](/documents/10803/941785/RI-MUHC+trainee+wins+scholarship+from+the+Soci%C3%A9t%C3%A9+qu%C3%A9b%C3%A9coise+d%E2%80%99hypertension+art %C3%A9rielle+thumbnail.jpg/a30e35f2-9c6e-96e3-0bc2-96a77fc76288?t=1591295701847)
RI-MUHC trainee wins scholarship from the Société québécoise d’hypertension artérielle
Congratulations to Joseph Mussa!
![](/documents/10803/946541/Hydroxychloroquine+not+effective+in+preventing+the+development+of+COVID-19+when+used+as+post-exposure+prophylaxis+thumbnail.jpg/fe1ba019-7e69-5922-5b03-f0fd08702057?t=1591274723048)
Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis
A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2
![](/documents/10803/919884/Results+of+MI4+Emergency+COVID-19+Research+Funding+%28Round+2%29+thumbnail.png/befd483e-ea19-c796-9d91-f9b002e69902?t=1590432255866)
Results of MI4 Emergency COVID-19 Research Funding (Round 2)
RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe
![](/documents/10803/896249/National+study+to+collect+data+on+aging+adults%E2%80%99+experiences+during+COVID-19+pandemic +thumbnail.png/3634aeb5-49b5-c734-538e-bd8f521fafb9?t=1588878586167)
National study to collect data on aging adults’ experiences during COVID-19 pandemic
Christina Wolfson is co-principal investigator on a new national study
![](/documents/10803/919884/Best+poster+presentation+at+meeting+of+the+CIHR+Drug+Safety+Effectiveness+Network +thumbnail.jpg/b9eced37-0f0b-ac75-f5a4-8b6a5ba8495a?t=1588612050998)
Best poster presentation at meeting of the CIHR Drug Safety Effectiveness Network
Congratulations to Marina Machado!
![](/documents/10803/896249/RI-MUHC+researchers+review+diagnostic+tests+for+COVID-19+thumbnail.jpg/1f0b1c68-a8a9-e141-672d-2b9095406521?t=1587391120359)
RI-MUHC researchers review diagnostic tests for COVID-19
Study published in the Annals of Internal Medicine
![](/documents/10803/896249/Results+of+MI4+Emergency+COVID-19+Research+Funding+%28Round+1%29+thumbnail.png/32953d4e-2d82-69b2-5319-cdf09acaaf23?t=1586893963482)
Results of MI4 Emergency COVID-19 Research Funding (Round 1)
RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe
![](/documents/10803/869435/Montreal+researchers+enter+the+race+against+COVID-19+with+an+innovative+clinical+trial_thumbnail.jpg/93c89e58-ac13-f465-9fc8-bbecbefb3940?t=1585680731401)
RI-MUHC innovative clinical trial assesses hydroxychloroquine for prevention and treatment of COVID-19
Initially restricted to health care workers in Quebec, the clinical study is now open to all eligible adults